{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:54:06Z","timestamp":1770994446279,"version":"3.50.1"},"reference-count":40,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,3,1]]},"DOI":"10.1210\/endo.138.3.4974","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T16:08:38Z","timestamp":1389197318000},"page":"1145-1150","source":"Crossref","is-referenced-by-count":44,"title":["The Effects of Growth Factors Associated with Osteoblasts on Prostate Carcinoma Proliferation and Chemotaxis: Implications for the Development of Metastatic Disease*"],"prefix":"10.1210","volume":"138","author":[{"given":"Candace K.","family":"Ritchie","sequence":"first","affiliation":[{"name":"Endocrine Research Unit, Department of Internal Medicine and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, Rochester Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura R.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Department of Internal Medicine and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, Rochester Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris G.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Department of Internal Medicine and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, Rochester Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Tindall","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Department of Internal Medicine and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, Rochester Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine A.","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Department of Internal Medicine and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, Rochester Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041122260237700_R1","first-page":"2498","article-title":"National Cancer Institute round table on prostate cancer: future research directions.","volume":"51","author":"Chiarodo","year":"1991","journal-title":"Cancer Res"},{"key":"2019041122260237700_R2","first-page":"329","article-title":"Mechanisms of metastasis: prostate cancer.","volume":"239","author":"Glaves","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"2019041122260237700_R3","first-page":"630","article-title":"Bone metastases: improving the therapeutic index.","volume":"21","author":"Scher","year":"1994","journal-title":"Semin Oncol"},{"key":"2019041122260237700_R4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jcem-73-4-785","article-title":"Human prostatic acid phosphatase directly stimulates collagen synthesis and alkaline phosphatase content of isolated bone cells.","volume":"73","author":"Ishibe","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122260237700_R5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast.","volume":"1","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"2019041122260237700_R6","first-page":"6030","article-title":"Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture.","volume":"50","author":"Fidler","year":"1990","journal-title":"Cancer Res"},{"key":"2019041122260237700_R7","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1002\/jbmr.5650081326","article-title":"Growth factors to stimulate bone formation","volume":"2","author":"Baylink","year":"1993","journal-title":"J Bone Miner Res [Suppl 8]"},{"key":"2019041122260237700_R8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/42.6.8189035","article-title":"Expression of mRNA for IL1 \u03b2, IL6 and TGF \u03b2 in developing human bone and cartilage.","volume":"42","author":"Dodds","year":"1994","journal-title":"J Histochem Cytochem"},{"key":"2019041122260237700_R9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1432-0436.1994.5520153.x","article-title":"Effects of transforming growth factor \u03b2 (TGF \u03b2) and 1,23 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.","volume":"55","author":"Ingram","year":"1994","journal-title":"Differentiation"},{"key":"2019041122260237700_R10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041600214","article-title":"TGF \u03b2 alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.","volume":"160","author":"Breen","year":"1994","journal-title":"J Cell Physiol"},{"key":"2019041122260237700_R11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0300-9084(93)90150-Q","article-title":"Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria.","volume":"75","author":"Panagakos","year":"1993","journal-title":"Biochimie"},{"key":"2019041122260237700_R12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/endo.135.1.8013362","article-title":"Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors.","volume":"135","author":"Gabbitas","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122260237700_R13","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption.","volume":"145","author":"Ishimi","year":"1990","journal-title":"J Immunol"},{"key":"2019041122260237700_R14","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1210\/endo.130.5.1572280","article-title":"Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 \u03b2 and tumor necrosis factor-\u03b1: lack of regulation by 17 \u03b2-estradiol.","volume":"130","author":"Chaudhary","year":"1992","journal-title":"Endocrinology"},{"key":"2019041122260237700_R15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1006\/bbrc.1994.1790","article-title":"Cytokines induce nitric oxide production in mouse osteoblasts.","volume":"201","author":"Damoulis","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122260237700_R16","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma.","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res"},{"key":"2019041122260237700_R17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijc.2910210305","article-title":"Isolation of a human prostate carcinoma cell line (DU145).","volume":"21","author":"Stone","year":"1978","journal-title":"Int J Cancer"},{"key":"2019041122260237700_R18","first-page":"16","article-title":"Establishment and characterization of a human prostatic cancer cell line (PC-3).","volume":"17","author":"Kaign","year":"1979","journal-title":"Invest Urol"},{"key":"2019041122260237700_R19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/endo.135.3.8070395","article-title":"Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations.","volume":"135","author":"Ritchie","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122260237700_R20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"2019041122260237700_R21","first-page":"381","article-title":"An improved method for the in vitro evaluation of monocyte leukotaxis.","volume":"90","author":"Campbell","year":"1977","journal-title":"J Lab Clin Med"},{"key":"2019041122260237700_R22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.92.1.227","article-title":"Recruitment of osteoclast precursors by purified bone matrix constituents.","volume":"92","author":"Malone","year":"1982","journal-title":"J Cell Biol"},{"key":"2019041122260237700_R23","first-page":"707","article-title":"Synthesis of messenger RNAs for transforming growth factors \u03b1 and \u03b2 and the epidermal growth factor receptor by human tumors.","volume":"47","author":"Derynck","year":"1987","journal-title":"Cancer Res"},{"key":"2019041122260237700_R24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jcem-73-2-401","article-title":"Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of prostate epithelial cells.","volume":"73","author":"Cohen","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122260237700_R25","first-page":"1031","article-title":"Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.","volume":"76","author":"Cohen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122260237700_R26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pros.2990220307","article-title":"Insulin-like growth factor 1: action and receptor characterization in human prostate cancer cell lines.","volume":"22","author":"Iwamura","year":"1993","journal-title":"Prostate"},{"key":"2019041122260237700_R27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/endo-126-1-39","article-title":"Receptor of insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.","volume":"126","author":"Centrella","year":"1990","journal-title":"Endocrinology"},{"key":"2019041122260237700_R28","first-page":"6447","article-title":"Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1.","volume":"52","author":"Pietrzowski","year":"1992","journal-title":"Cancer Res"},{"key":"2019041122260237700_R29","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/jcem.80.12.8530586","article-title":"Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine loop.","volume":"80","author":"Figueroa","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122260237700_R30","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1210\/endo.136.12.7588299","article-title":"Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).","volume":"136","author":"Angelloz-Nicoud","year":"1995","journal-title":"Endocrinology"},{"key":"2019041122260237700_R31","first-page":"987","article-title":"Endogenous cathepsin D-mediated hydrolysis of the insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells.","volume":"80","author":"Conover","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122260237700_R32","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ijc.2910420622","article-title":"Regulation of growth and epidermal growth factor receptor levels in LNCaP prostate tumor cells by different steroids.","volume":"42","author":"Schuurmans","year":"1989","journal-title":"Int J Cancer"},{"key":"2019041122260237700_R33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.105.3.1039","article-title":"Some recent advances in the chemistry and biology of transforming growth factor \u03b2.","volume":"105","author":"Sporn","year":"1987","journal-title":"J Cell Biol"},{"key":"2019041122260237700_R34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.2990160304","article-title":"Production of transforming growth factor \u03b1 by the androgen responsive LNCaP human prostate cancer cell line.","volume":"16","author":"Connolly","year":"1990","journal-title":"Prostate"},{"key":"2019041122260237700_R35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0303-7207(89)90115-9","article-title":"Differential effects of transforming growth factor \u03b2 on human prostate cancer cells in vitro.","volume":"62","author":"Wilding","year":"1989","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122260237700_R36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(17)37748-0","article-title":"Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor.","volume":"146","author":"Tjota","year":"1991","journal-title":"J Urol"},{"key":"2019041122260237700_R37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0960-0760(91)90182-5","article-title":"Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.","volume":"40","author":"Schuurmans","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122260237700_R38","first-page":"7786","volume":"50","author":"Siegall","journal-title":"Cancer Res"},{"key":"2019041122260237700_R39","first-page":"91","article-title":"Selective formation of tumor necrosis factor-\u03b1 (TNF) degradation products contributed to TNF mediated cytotoxicity.","volume":"4","author":"Fruehauf","year":"1992","journal-title":"Oncol Res"},{"key":"2019041122260237700_R40","first-page":"44","article-title":"Therapeutic efficacy of recombinant tumor necrosis factor \u03b1 in an experimental model of human prostatic carcinoma.","volume":"9","author":"Sherwood","year":"1990","journal-title":"J Biol Response Mod"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/138\/3\/1145\/10357630\/endo1145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T18:12:58Z","timestamp":1716401578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/138\/3\/1145\/2988036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endo.138.3.4974","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3,1]]}}}